Critical NIH research continues after 'confusion' over Trump team directives
Despite concerns about the future of research at the National Institutes of Health, current clinical trials can continue as scheduled, the agency’s acting director told staff scientists in an email Monday.
Despite concerns about the future of research at the National Institutes of Health, current clinical trials can continue as scheduled, the agency’s acting director told staff scientists in an email Monday.
The clarification followed what staffers called “chaos” Wednesday when the Trump administration “paused” all communications from federal health agencies and suspended all government travel. The directive left NIH staff members with unanswered questions about their work and even whether they’d be able to continue caring for their patients.
The acting director, Dr. Matthew Memoli, a longtime infectious disease expert and flu vaccine researcher at the NIH, wrote in the email, a copy of which was obtained by NBC News, that he sought to clear up “confusion on the scope of the pause.”
“Clinical trials at NIH or NIH-funded institutions are ongoing,” he wrote. “Research participants can continue to participate in clinical trials at the NIH Clinical Center and at NIH-funded facilities.”
He also clarified that investigators could continue to spend money on supplies and pay for research participants to travel to the NIH Clinical Center in Bethesda, Maryland, for treatment. The NIH conducts more than a thousand clinical trials every year.
https://www.nbcnews.com/health/health-news/nih-research-trump-continue-confusion-rcna189494
Rating: 5